Cohort studyindependent cross-checkabstract only checked I-ABX-08 standard review

Antibiotic timing in septic shock

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Overview

Kumar A et al.. Crit Care Med 2006 · PMID 16625125 · DOI 10.1097/01.CCM.0000217961.75225.E9

Each hour of delay reduced survival by about 7.6% on average.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Assess delay.

How was the study done?

Cohort.

How many people, animals or samples were studied?

2154 patients.

What was actually found?

Delay worsens survival.

How large was the observed effect?

-7.6% per hour.

What do the results mean in everyday life?

Antibiotics are life-saving here.

What are the study's limitations?

Retrospective.

What does it say about Elawady's specific claim?

Contradicts claim.

Do the results apply to Germany and Europe?

High.

Scientific in-depth review

1. Full reference

Authors
Kumar A et al.
Journal
Crit Care Med
Year
2006
Identifier
PMID 16625125 DOI 10.1097/01.CCM.0000217961.75225.E9
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract/record

2. Research question

Does delay in effective antimicrobials after hypotension affect survival in septic shock?

3. Study design and population

Study design
Cohort study – Retrospective multicentre cohort
Population

Adults with septic shock

Country

Canada and USA

Period

1989-2004

Sample size

2731 (2154 analysed)

Inclusion and exclusion criteria

Septic shock

4. Methods and endpoints

Exposure / intervention

Time to effective antimicrobial

Comparator

Within first hour

Endpoints

Survival to discharge

Statistical methods

Adjusted OR

5. Actual results

Results

aOR 1.119 per hour delay (1.103-1.136); survival 79.9% if within first hour; average 7.6% decrease in survival per hour over 6 hours.

Absolute risks

Survival 79.9% with therapy in first hour.

Authors' conclusion

Time to effective antimicrobial therapy was the strongest predictor of outcome.

6. Strengths

  • Multicentre

7. Weaknesses

  • Retrospective

8. Risk of bias

Orienting tool
ROBINS-I
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns

9. Assessment of the statistical interpretation

10. Relevance to the specific claim

Contradicts C-ABX-12.

11. Independent contrary findings

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Classic evidence.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultshigh
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks